Step 6: Request an expedited appeal if medically urgent
Over time, a patient (under the guidance of their practitioner) may gradually increase their dose up to a maximum of 2.4mg, depending on each persons individual response to the medication
Atherosclerosis, the primary driver of CVD in T2D, underlies 85.8% of cases in the 34.8% of T2D patients globally with established CVD [7]
It corresponds directly with the visible and measurable decline in tissue repair capacity that most people associate with aging: slower wound healing, reduced skin elasticity, thinning hair, and longer recovery times after physical stress
Why Temperature Matters GLP-1 monitoring and storage are vital because these medications are highly sensitive and must be kept between 2 C and 8 C
Similarly, as a result of the positive findings from the recent DAPA-CKD trial [90], dapagliflozin is now indicated for the treatment of CKD, and can be initiated if eGFR 25 ml/min/1.73 m 2